O.K.
"Under the terms of the agreement, MCIT will develop three ADC product candidates which contain OXIS’ lead drug candidates OXS-2175 and OXS-4235. OXIS paid MCIT a license fee of $500,000"
Interesting it's two wholly owned subsidiaries, who don't have to report anything. How do you license something for which intellectual property doesn't exist?
O.K., not to worry, I know the deal and how things work.
good luck!
News 
Market Data 
Discover 
